Table 1. Knowledge on cervical cancer and screening (n=357).
Items | Values | |
---|---|---|
Definition of cervical cancer | 87 (24.4) | |
Signs and symptoms | ||
No symptoms in early-stage | 43 (13.2) | |
Post-coital bleeding | 93 (25.4) | |
Post-menopausal bleeding | 86 (26.4) | |
Dyspareunia | 99 (30.2) | |
Increased vaginal discharge | 146 (44.2) | |
Risk factors | ||
Multiple sexual partners | 147 (41.5) | |
Multiple pregnancies | 168 (47.5) | |
Early marriage | 199 (56.1) | |
Tobacco smoking | 39 (11.0) | |
Low socioeconomic status | 34 (9.6) | |
Long-term OCP use | 54 (15.2) | |
HPV infection | 60 (16.9) | |
Prevention of cervical cancer | ||
No multiple sexual partners | 150 (42.3) | |
Avoiding multiple pregnancies | 159 (44.9) | |
Use of condom instead of long-term OCP | 58 (16.3) | |
Avoiding early marriage/early sexual debut | 135 (37.9) | |
HPV immunization | 74 (20.7) | |
Maintaining good personal hygiene | 114 (32.1) | |
Regular cervical screening | 93 (26.3) | |
Proper treatment of sexually transmitted infections | 64 (18.0) | |
Cervical cancer is treatable if detected early | 178 (49.9) | |
Ideal time to start cervical cancer screening | 76 (21.4) | |
Screening interval | 35 (9.8) | |
When to stop cervical cancer screening | 57 (17.2) | |
Available screening tests | ||
Pap smear | 72 (21.8) | |
HPV test | 31 (9.4) | |
VIA | 3 (0.9) |
Values are presented as correct response (%).
HPV, human papillomavirus; OCP, oral contraceptive pill; VIA, Visual Inspection with Acetic Acid.